Subscribe to stay informed!
Devon-based Zynerba Pharmaceuticals saw its shares surge after it received a U.S. patent for its cannabidiol (CBD) gel to treat Autism Spectrum Disorders…
Before we send you to this site, please subscribe to our daily newsletter.